Financial

Home/Financial

A Hot Spot for Biotech Jobs

GEN has its new list of hubs that are "hot spots" for biotech jobs, and while there's no ranking of the hubs, San Diego (along with the other Big3Bio regions) is highlighted as one of the top in the country. From GEN/Editor Alex Philippidis: "GEN generated its list of the top 10 U.S. regions in which to [...]

November 30th, 2015|

The California Life Sciences Industry: A Powerful Economic Engine

California Life Sciences Association (CLSA) and PwC US have released the 2016 California Life Sciences Industry Report, which indicates that California’s life sciences sector had a profound impact on the state’s economy, "showing industry increases in the areas of sector employment growth, wages, research funding and life sciences venture investment." “Our latest report paints a vivid picture of California’s 2,848 [...]

November 13th, 2015|

Avalon, GSK Expand Biotech Deal

Excerpts from coverage of Avalon and GSK expanding their collaboration to fund and launch early-stage life science companies in San Diego (the collaboration is now worth up to a potential additional $60 million in combined funding and earn-outs per company if the company develops marketed products): San Diego Union Tribune: "An international drug giant and a La [...]

November 9th, 2015|

Ultragenyx, Arcturus in Potential $1.56B+ Rare Disease Collaboration

Coverage of the Big3Bio-area companies' launching of an up-to-$1.56B+ rare disease collaboration: BioWorld: Ultragenyx gives Arcturus rocket shot in potential $1.57B deal "The up front is only $10 million, but Arcturus Therapeutics Inc. stands to collect up to $1.56 billion more from Ultragenyx Pharmaceutical Inc. in a rare disease research collaboration and license deal to [...]

October 29th, 2015|

Imprimis to Offer $1 Pill After Turing Price Hike Outrage; Shkreli Calls it a “Publicity Stunt”

The intro from The Daily Mail's coverage of Imprimis Pharmaceuticals' Imprimis Cares program and announcement: "Stepping into the furor over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was jacked up to $750 per pill by Turing Pharmaceuticals. San Diego-based Imprimis Pharmaceuticals Inc., which mixes [...]

October 23rd, 2015|

The Huge Impact of San Diego Research Centers

Coverage of the San Diego Regional Economic Development Corp's new report about San Diego research centers bringing $4.6B to the local economy: KPBS: Report: San Diego Research Institutes Have A $4.6 Billion Impact "The San Diego Regional Economic Development Corp. pegs the local impact of nonprofit research institutes at $4.6 billion each year. "Which is the equivalent of 34 [...]

October 14th, 2015|

Blackstone to Buy BioMed Realty in $8 Billion Deal

Coverage of BioMed Realty -- San Diego-based and prominent in Big3Bio regions -- being bought by Blackstone: Press release: BioMed Realty Enters Into Definitive Agreement To Be Acquired By Blackstone For $23.75 Per Share In $8 Billion Transaction "We are excited to acquire this best-in-class company which owns an exceptional collection of office buildings catering to life science tenants in [...]

October 8th, 2015|

San Diego’s Path to Biotech Success

As Bradley J. Fikes mentions in the intro of his recent feature about San Diego biotech -- it's hard to have the success the way the "Big 3" have in the industry, and he goes into how "long-term planning, cooperation, science and business talent, money vaulted (the San Diego) region to top ranks." Excerpt: "Leading biomedical hubs such [...]

September 14th, 2015|

Report: San Diego A Top Region in 2Q Funding

The PwC/MoneyTree Life Sciences Report: Quarterly Q2 2015 is out, and San Diego is one of the top regions in funding. Other highlights/notes in the report: Compared with the same quarter a year ago, first-time funding for the life sciences sector rose 245% to $858 million, and the number of deals rose 26% to 44 [...]

August 27th, 2015|

Illumina, Ligand Make Fortune’s Fastest-Growing List

The 2015 edition of Fortune's 100 Fastest Growing Companies list is out and two of the nine life science companies that made the list were Illumina and Ligand Pharmaceuticals. Each company's profile from Fortune: #18 - Ligand Pharmaceuticals #28 - Illumina Full 100-company list Main Fortune 100 Fastest Company section

August 19th, 2015|

The DexCom-Google Deal

Coverage after announcement of medical device-maker DexCom partnering with Google Life Sciences to develop a new generation of glucose monitors for people with diabetes: FierceBiotech Google joins forces with Dexcom for miniaturized glucose monitor Fool.com DexCom Taps Google to Build Miniature Diabetes Sensors mobihealthnews DexCom taps Google for smaller, cheaper diabetes devices MedDeviceOnline Google, Dexcom Team [...]

August 12th, 2015|

primeUC: Seeding UC’s Top Startups

From the primeUC website primeUC is part of UC President Janet Napolitano’s Initiative on Innovation and Entrepreneurship. Each primeUC event will award seed funding to the most promising start-ups emerging from the University of California.  We plan to host 2-4 events per year, rotating between Life Sciences and Engineering.  The primeUC event will bring together 20 [...]

August 6th, 2015|

Lilly Yanks Millions From UCSD

"Lilly yanks millions from UCSD for Alzheimer's study" That's the headline from UT-San Diego on the latest turn of the UCSD-USC Alzheimer's study battle; this development is a "major blow" to UCSD. Coverage: UT-San Diego LA Times: USC gets funds for Alzheimer's medicine research Times of San Diego: Costly Blow to UCSD: Eli Lilly Cutting Ties on Alzheimer’s [...]

August 5th, 2015|

Big3Bio Regions Dominate 2015 JLL Rankings

The commercial real estate services' firm JLL has put out its annual Life Sciences Outlook report, and the Big 3 regions again dominate their latest analysis and ratings of the top life science hubs in the country. In this year's report, San Diego comes in at #4 -- a look at the weights/factors in JLL's rankings : More information and link [...]

July 23rd, 2015|

More on Celgene-Receptos Deal

Initial coverage from Big3Bio Additional coverage: San Diego Union-Tribune: Celgene buys Receptos for $7.3 billion "Receptos and Celgene valued the deal at $7.2 billion excluding Receptos' cash on hand. That's larger than all but a few local biotech purchases, the biggest of which was the $13.6 billion purchase of Carlsbad's Life Technologies by Thermo Fisher [...]

July 16th, 2015|

Celgene to Acquire Receptos

Coverage of the $7.2B deal: (7/15) FierceBiotech: Celgene's $7.2B buyout gets a big thumbs up, but is the deal really done? "Downside remarks tend to caution against looking for a higher share price, and one analyst at least raises the prospect that the bidding war may not be over." Full article (7/15) TheStreet: Thoughts, Appraisals, Lingering Questions [...]

July 15th, 2015|

UCSD Sues USC, Alzheimer’s Researcher

Coverage of UCSD's lawsuit against USC and Dr. Paul Aisen: UCSD will ask court to protect Alzheimer's data (San Diego Tribune) "UC San Diego says it will seek a temporary restraining order against a former professor and the University of Southern California to prevent them from changing data the campus has been collecting in a landmark study [...]

July 6th, 2015|

Celladon Coverage

Excerpt from press release: "Our Board of Directors has unanimously determined that seeking a merger or sale, in lieu of further development of our remaining programs and assets, gives us the best opportunity to maximize shareholder value. We are aggressively pursuing that course," said Paul Cleveland, president and chief executive officer of Celladon. "If we [...]

June 29th, 2015|

Pledging NOT to Make Money

From caption: There’s a lot of money to be made in the biotech industry. So imagine forming a biotech company that pledges not to make money. That’s what a San Diego chemist has done. What’s more, his non-profit biotech specializes in neglected tropical diseases. KPBS Health Reporter Kenny Goldberg takes a look at a firm that’s [...]

June 23rd, 2015|

More on Avalon Launching Startups

From UT-San Diego: "Crossing the halfway point in their alliance to form up to 10 biotech companies in San Diego, La Jolla's Avalon Ventures and UK-based GlaxoSmithKline said Monday they have added three new companies to their portfolio. Adrenergics, CadheRx Therapeutics, and Calporta Therapeutics, will each receive up to $10 million, along with research and [...]

June 16th, 2015|
X